Galectin Therapeutics Return on Assets:
-86.04% for Dec. 31, 2012Galectin Therapeutics Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -86.04% |
| Sept. 30, 2012 | -97.38% |
| June 30, 2012 | -96.70% |
| March 31, 2012 | -115.0% |
| Dec. 31, 2011 | -150.3% |
| Sept. 30, 2011 | -126.6% |
| June 30, 2011 | -133.1% |
| March 31, 2011 | -148.8% |
| Dec. 31, 2010 | -215.2% |
| Sept. 30, 2010 | -365.8% |
| June 30, 2010 | -486.8% |
| March 31, 2010 | -842.1% |
| Dec. 31, 2009 | -818.6% |
| Sept. 30, 2009 | -711.8% |
| June 30, 2009 | -460.6% |
| March 31, 2009 | -208.2% |
| Dec. 31, 2008 | -164.6% |
| Sept. 30, 2008 | -172.7% |
| June 30, 2008 | -262.0% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
GALT Return on Assets Benchmarks
| Companies | |
|---|---|
| Acura Pharmaceuticals | -37.83% |
| Catalyst Pharmaceutical Partners | -42.61% |
| AVANIR Pharmaceuticals | -66.59% |
GALT Return on Assets Rankings
| Overall |
37th percentile 4733 of 7590 |
| Sector |
23rd percentile 500 of 651 in Healthcare |
| Industry |
23rd percentile 50 of 65 in Drug Manufacturers - Specialty & Generic |
GALT Return on Assets Range, Past 5 Years
| Minimum | -842.1% | Mar 2010 |
| Maximum | -86.04% | Dec 2012 |
| Average | -298.0% |
